184 related articles for article (PubMed ID: 25023357)
1. Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters.
Carr BI; Pancoska P; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Semin Oncol; 2014 Jun; 41(3):406-414. PubMed ID: 25023357
[TBL] [Abstract][Full Text] [Related]
2. Macro- and micro-environmental factors in clinical hepatocellular cancer.
Pancoska P; Carr BI
Semin Oncol; 2014 Apr; 41(2):185-94. PubMed ID: 24787292
[TBL] [Abstract][Full Text] [Related]
3. Platelet-related phenotypic patterns in hepatocellular carcinoma patients.
Carr BI; Lin CY; Lu SN
Semin Oncol; 2014 Jun; 41(3):415-21. PubMed ID: 25023358
[TBL] [Abstract][Full Text] [Related]
4. Significance of platelet and AFP levels and liver function parameters for HCC size and survival.
Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Int J Biol Markers; 2014 Sep; 29(3):e215-23. PubMed ID: 24526315
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.
Akkiz H; Carr BI; Yalçın K K; Guerra V; Kuran S; Altıntaş E; Üsküdar O; Karaoğullarından Ü; Özakyol A; Tokmak S; Yücesoy M; Bahçeci Hİ; Ülkü A; Akçam T; Yalçın Polat K; Ekinci N; Şimşek H; Örmeci N; Sonsuz A; Demir M; Kılıç M; Uygun A; Ballı T; Demir A; Arslan B; Doran F
Oncology; 2018; 94(2):116-124. PubMed ID: 29207378
[TBL] [Abstract][Full Text] [Related]
6. Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.
Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Ludovico Rapaccini G; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Semin Oncol; 2014 Apr; 41(2):252-8. PubMed ID: 24787296
[TBL] [Abstract][Full Text] [Related]
7. Low alpha-fetoprotein HCC and the role of GGTP.
Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F
Int J Biol Markers; 2014 Dec; 29(4):e395-402. PubMed ID: 24832180
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.
Farinati F; Vitale A; Spolverato G; Pawlik TM; Huo TL; Lee YH; Frigo AC; Giacomin A; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Sacco R; Morisco F; Biasini E; Foschi FG; Gasbarrini A; Svegliati Baroni G; Virdone R; Masotto A; Trevisani F; Cillo U;
PLoS Med; 2016 Apr; 13(4):e1002006. PubMed ID: 27116206
[TBL] [Abstract][Full Text] [Related]
9. Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
Carr BI; Guerra V
Dig Dis Sci; 2016 Mar; 61(3):937-47. PubMed ID: 26576554
[TBL] [Abstract][Full Text] [Related]
10. Relationships Between Indices of Tumor Aggressiveness in Hepatocellular Carcinoma.
Carr BI; Guerra V; Donghia R; Yilmaz S
J Gastrointest Cancer; 2021 Dec; 52(4):1340-1349. PubMed ID: 34611834
[TBL] [Abstract][Full Text] [Related]
11. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma.
Carr BI; Guerra V; Pancoska P
Oncology; 2012; 83(6):339-45. PubMed ID: 23006937
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
14. Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.
Chan SL; Mo F; Johnson P; Li L; Tang N; Loong H; Chan AW; Koh J; Chan AT; Yeo W
J Gastroenterol Hepatol; 2015 Oct; 30(10):1529-35. PubMed ID: 25968302
[TBL] [Abstract][Full Text] [Related]
15. Triple positive tumor markers for hepatocellular carcinoma are useful predictors of poor survival.
Kiriyama S; Uchiyama K; Ueno M; Ozawa S; Hayami S; Tani M; Yamaue H
Ann Surg; 2011 Dec; 254(6):984-91. PubMed ID: 21606837
[TBL] [Abstract][Full Text] [Related]
16. Histological differentiation predicts post-liver transplantation survival time.
Li WX; Li Z; Gao PJ; Gao J; Zhu JY
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):201-8. PubMed ID: 24388339
[TBL] [Abstract][Full Text] [Related]
17. AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.
Yaprak O; Akyildiz M; Dayangac M; Demirbas BT; Guler N; Dogusoy GB; Yuzer Y; Tokat Y
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):256-61. PubMed ID: 22672818
[TBL] [Abstract][Full Text] [Related]
18. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
19. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
20. Small hepatocellular carcinomas and thrombocytopenia.
Carr BI; Guerra V; De Giorgio M; Fagiuoli S; Pancoska P
Oncology; 2012; 83(6):331-8. PubMed ID: 23006906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
